New Delhi, Feb 9 (PTI) Natco Pharma on Thursday said its consolidated net profit declined by 22 per cent to Rs 62 crore for the third quarter ended December 31, 2022.

The Hyderabad-based drug firm had reported a net profit of Rs 80 crore in the October-December quarter of last fiscal.

Also Read | Education Ministry Says No Proposal To Convert Existing Institute, Varsity Into Central University.

Total income of the company stood at Rs 513 crore in the period under review as compared with Rs 591 crore in the year-ago period that had a one-time licensing revenue.

The company's board, which met on Thursday, approved an interim dividend of Rs 1.25 per share for the quarter ended December 31, 2022.

Also Read | Punjab State Dear Mahashivratri Bumper Lottery 2023: Know Prize Money, Draw Result Date And Other Details.

Shares of the company ended 0.38 per cent down at Rs 529.10 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)